Last reviewed · How we verify
Irritable bowel syndrome
Approved treatments
- MEBEVERINE
- Chlordiazepoxide Hydrochloride · Bausch Health
- Librax · Roche
- Bentyl · Forest Labs Inc
- Linzess · AbbVie
Linzess works by activating the heat-stable enterotoxin receptor to increase fluid secretion in the intestines. - Hycodan · Endo
Hycodan works by affecting the nervous system to reduce cough and relieve symptoms of irritable bowel syndrome and peptic ulcer. - Linzess · TriHealth Inc.
- Homatropin
- Methylscopolamine · Fougera Pharms
- scopolamin · University Hospital, Angers
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Irritable bowel syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Irritable bowel syndrome treatment landscape brief
- Irritable bowel syndrome treatment updates RSS
Frequently asked questions about Irritable bowel syndrome
What drugs treat Irritable bowel syndrome?
Tracked treatments include MEBEVERINE, Chlordiazepoxide Hydrochloride, Librax, Bentyl, Linzess, Hycodan, Homatropin, Methylscopolamine.
What is the treatment for Irritable bowel syndrome?
Standard treatment for Irritable bowel syndrome includes MEBEVERINE, Chlordiazepoxide Hydrochloride, Librax, Bentyl, Linzess. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Irritable bowel syndrome patent cliff · Irritable bowel syndrome CI report
- Treatment: MEBEVERINE
- Treatment: Chlordiazepoxide Hydrochloride · Bausch Health
- Treatment: Librax · Roche
- Treatment: Bentyl · Forest Labs Inc
- Treatment: Linzess · AbbVie
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing